These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19289781)

  • 41. Medullary thyroid cancer treated by capecitabine.
    Labidi SI; Gravis G; Tarpin C; Brun V; Viens P
    Anticancer Drugs; 2007 Aug; 18(7):831-4. PubMed ID: 17581307
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Severe toxicity after treatment with capecitabine and fluorouracil due to partial dihydropyrimidine dehydrogenase deficiency].
    Hooiveld EA; van Kuilenburg AB; Haanen JB; Westermann AM
    Ned Tijdschr Geneeskd; 2004 Mar; 148(13):626-8. PubMed ID: 15083629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Single-agent capecitabine maintenance therapy after response to capecitabine-based combination chemotherapy in patients with metastatic breast cancer.
    Huang H; Jiang Z; Wang T; Zhang S; Bian L; Cao Y; Wu S; Song S
    Anticancer Drugs; 2012 Aug; 23(7):718-23. PubMed ID: 22739713
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An open-label, multicenter study of outpatient capecitabine monotherapy in 631 patients with pretreated advanced breast cancer.
    Venturini M; Paridaens R; Rossner D; Vaslamatzis MM; Nortier JW; Salzberg M; Rodrigues H; Bell R
    Oncology; 2007; 72(1-2):51-7. PubMed ID: 18004077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subacute cutaneous lupus erythematosus induced by chemotherapy: gemcitabine as a causative agent.
    Wiznia LE; Subtil A; Choi JN
    JAMA Dermatol; 2013 Sep; 149(9):1071-5. PubMed ID: 23842655
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Early diagnosis of capecitabine-induced acute leukoencephalopathy by using diffusion-weighted MRI].
    Shimoyama R; Ban T; Miyake K; Isogai N; Ikegaya Y; Kawachi J; Ogino H; Watanabe K
    Gan To Kagaku Ryoho; 2014 Oct; 41(10):1251-3. PubMed ID: 25335709
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Study of tolerability of capecitabine in postoperative adjuvant chemotherapy in colon cancer].
    Matsuda C; Tamagawa H; Nishikawa K; Deguchi T; Kawata J; Iwase K; Takagi M; Fukui A; Nezu R; Tanaka Y
    Gan To Kagaku Ryoho; 2013 Mar; 40(3):327-30. PubMed ID: 23507593
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Occurrence of subacute cutaneous lupus erythematosus after treatment with systemic fluorouracil.
    Almagro BM; Steyls MC; Navarro NL; Domínguez EG; Acosta EH; Pérez MA; Ceballos EH
    J Clin Oncol; 2011 Jul; 29(20):e613-5. PubMed ID: 21537030
    [No Abstract]   [Full Text] [Related]  

  • 49. [Toxic dermatitis due to capecitabine: presentation of 2 cases and literature review].
    Gutiérrez-Pascual M; Sols-Candela M; Pinedo F; López-Estebaranz JL
    Actas Dermosifiliogr; 2009 May; 100(4):336-8. PubMed ID: 19463243
    [No Abstract]   [Full Text] [Related]  

  • 50. [Use of xeloda (capecitabine) in the treatment of cancer patients (review)].
    Orel NF
    Ter Arkh; 2003; 75(10):65-70. PubMed ID: 14669610
    [No Abstract]   [Full Text] [Related]  

  • 51. Capecitabine monotherapy for recurrent and metastatic nasopharyngeal cancer.
    Chua D; Wei WI; Sham JS; Au GK
    Jpn J Clin Oncol; 2008 Apr; 38(4):244-9. PubMed ID: 18407933
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis.
    Das P; Lin EH; Bhatia S; Skibber JM; Rodriguez-Bigas MA; Feig BW; Chang GJ; Hoff PM; Eng C; Wolff RA; Delclos ME; Krishnan S; Janjan NA; Crane CH
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1378-83. PubMed ID: 17056196
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Ileitis following capecitabine use].
    Bouma G; Imholz AL
    Ned Tijdschr Geneeskd; 2011; 155():A3064. PubMed ID: 21486509
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of capecitabine in cancer: management of the hand foot syndrome.
    Sudoyo AW
    Acta Med Indones; 2005; 37(3):174-6. PubMed ID: 16110178
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical picture: leopard-like vitiligo with capecitabine.
    Schmid-Wendtner MH; Wendtner CM; Volkenandt M; Heinemann V
    Lancet; 2001 Nov; 358(9293):1575. PubMed ID: 11716883
    [No Abstract]   [Full Text] [Related]  

  • 56. [Prinzmetal's angina in a patient treated with capecitabine: a case study].
    Becerril Moreno F; González Sanchez J; Arteche Eguizabal L
    Farm Hosp; 2010; 34(5):262-4. PubMed ID: 20167524
    [No Abstract]   [Full Text] [Related]  

  • 57. Severe or lethal toxicities upon capecitabine intake: is DPYD genetic polymorphism the ideal culprit?
    Mercier C; Ciccolini J
    Trends Pharmacol Sci; 2007 Dec; 28(12):597-8. PubMed ID: 18001850
    [No Abstract]   [Full Text] [Related]  

  • 58. Capecitabine in the management of colorectal cancer.
    Maroun JA
    Expert Rev Anticancer Ther; 2001 Oct; 1(3):327-33. PubMed ID: 12113099
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacology and therapeutic efficacy of capecitabine: focus on breast and colorectal cancer.
    Aprile G; Mazzer M; Moroso S; Puglisi F
    Anticancer Drugs; 2009 Apr; 20(4):217-29. PubMed ID: 19247178
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coronary spasm induced by capecitabine mimicks ST elevation myocardial infarction.
    Scott PA; Ferchow L; Hobson A; Curzen NP
    Emerg Med J; 2008 Oct; 25(10):699-700. PubMed ID: 18843078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.